Pink Kush
Commercial- Indications
- Medical cannabis
Company intelligence / Profile preview
Canna Farms was the first licensed producer of medical cannabis in British Columbia, Canada. It offers over a hundred medically-focused products across multiple brands, including dried flower, oils, edibles, extracts, and vapes. The company emphasizes quality control with hand-selected and hand-packaged buds and provides transparent potency testing for each lot. It has a strong focus on patient care programs—including support for veterans—and direct billing services[1][2][6]. Clinical results are not published in the traditional pharmaceutical sense but patient outcomes are tracked through partnerships like Strainprint[1].
Since its acquisition by VIVO Cannabis and subsequent integration into MediPharm Labs' operations in mid/late 2023, Canna Farms continues to operate as a leading Canadian medical channel[4].
Pipeline breadth or formal drug development pipeline does not apply; instead the company offers a broad portfolio of commercialized product SKUs.
No traditional clinical trial pipeline exists due to regulatory framework for medical cannabis.
The company’s business model centers on providing regulated access to high-quality medicinal cannabis rather than developing single-molecule drugs through staged clinical trials.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canna Farms.